Strata Critical Medical Inc
SRTA
105 hedge funds and large institutions have $89.1M invested in Strata Critical Medical Inc in 2023 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 32 increasing their positions, 24 reducing their positions, and 6 closing their positions.
217% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 6
33% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 24
13% more funds holding
Funds holding: 93 → 105 (+12)
3.28% less ownership
Funds ownership: 49.69% → 46.41% (-3.3%)
38% less capital invested
Capital invested by funds: $143M → $89.1M (-$54.1M)
45% less call options, than puts
Call options by funds: $802K | Put options by funds: $1.47M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UIC
Uniplan Investment Counsel
Milwaukee,
Wisconsin
|
+$2.48M |
| 2 |
JP Morgan Chase
New York
|
+$1.97M |
| 3 |
Morgan Stanley
New York
|
+$1.78M |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$1.67M |
| 5 |
Cerity Partners
New York
|
+$1.27M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HVCM
HG Vora Capital Management
New York
|
-$10.8M |
| 2 |
Goldman Sachs
New York
|
-$6.46M |
| 3 |
NRCM
Northern Right Capital Management
Darien,
Connecticut
|
-$1.49M |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
-$930K |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$930K |
SRTA Hedge Fund Activity: Q3 2023 in Review
105 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical Inc (SRTA) for Q3 2023, worth a combined $89.1M — down 38% from $143M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new SRTA positions and 6 closed out — a net gain of 13 holders — while 32 added to existing stakes and 24 trimmed.
The largest buyer was Uniplan Investment Counsel, opening a new position worth an estimated $2.48M. The largest seller was HG Vora Capital Management, exiting entirely with an estimated $10.8M sold.
- 105 institutional investors held Strata Critical Medical Inc (SRTA) as of Q3 2023, up from 93 in Q2 2023.
- Funds reported $89.1M of Strata Critical Medical Inc stock for Q3 2023, down 38% quarter-over-quarter.
- 19 funds opened new Strata Critical Medical Inc positions in Q3 2023 and 6 closed out, a net change of +13 holders.
- The largest Strata Critical Medical Inc buyer in Q3 2023 was Uniplan Investment Counsel, an estimated $2.48M added.
- The largest Strata Critical Medical Inc seller in Q3 2023 was HG Vora Capital Management, an estimated $10.8M sold.
Based on aggregated 13F filings for Q3 2023.